Inhibition of the platelet P2Y12receptor for adenosine diphosphate does not impair the capacity of platelet to synthesize thromboxane A2
Author:
Funder
AstraZeneca
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/article-pdf/37/44/3347/8605568/ehv551.pdf
Reference30 articles.
1. New P2Y12Inhibitors
2. Aspirin has little additional anti‐platelet effect in healthy volunteers receiving prasugrel
3. Antagonism of P2Y12reduces physiological thromboxane levels
4. In the presence of strong P2Y12 receptor blockade, aspirin provides little additional inhibition of platelet aggregation
5. Dual antiplatelet therapy in cardiovascular disease: does aspirin increase clinical risk in the presence of potent P2Y12 receptor antagonists?
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impairment of platelet function in both mild and severe COVID‐19 patients;British Journal of Haematology;2023-08-24
2. QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y12) antagonist;RSC Medicinal Chemistry;2023
3. Pharmacokinetic and Pharmacodynamic Profile of a Novel Phospholipid Aspirin Formulation;Clinical Pharmacokinetics;2022-01-20
4. Ultra-high-throughput Ca2+ assay in platelets to distinguish ITAM-linked and G-protein-coupled receptor activation;iScience;2022-01
5. P2Y12 antagonists: Approved drugs, potential naturally isolated and synthesised compounds, and related in-silico studies;European Journal of Medicinal Chemistry;2022-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3